Literature DB >> 8823306

Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.

M Costas1, T Trapp, M P Pereda, J Sauer, R Rupprecht, V E Nahmod, J M Reul, F Holsboer, E Arzt.   

Abstract

Cytokine-induced glucocorticoid secretion and glucocorticoid inhibition of cytokine synthesis and pleiotropic actions act as important safeguards in preventing cytokine overreaction. We found that TNF-alpha increased glucocorticoid-induced transcriptional activity of the glucocorticoid receptor (GR) via the glucocorticoid response elements (GRE) in L-929 mouse fibroblasts transfected with a glucocorticoid-inducible reporter plasmid. In addition, TNF-alpha also enhanced GR number. The TNF-alpha effect on transcriptional activity was absent in other cell lines that express TNF-alpha receptors but not GRs, and became manifest when a GR expression vector was cotransfected, indicating that TNF-alpha, independent of any effect it may have on GR number, has a stimulatory effect on the glucocorticoid-induced transcriptional activity of the GR. Moreover, TNF-alpha increased GR binding to GRE. As a functional biological correlate of this mechanism, priming of L-929 cells with a low (noncytotoxic) dose of TNF-alpha significantly increased the sensitivity to glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. TNF-alpha and IL-1 beta had the same stimulatory action on glucocorticoid-induced transcriptional activity of the GR via the GRE, in different types of cytokine/glucocorticoid target cells (glioma, pituitary, epithelioid). The phenomenon may therefore reflect a general molecular mechanism whereby cytokines modulate the transcriptional activity of the GR, thus potentiating the counterregulation by glucocorticoids at the level of their target cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823306      PMCID: PMC507567          DOI: 10.1172/JCI118928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  General presence of glucocorticoid receptors in mammalian tissues.

Authors:  P L Ballard; J D Baxter; S J Higgins; G G Rousseau; G M Tomkins
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

2.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma.

Authors:  P Herbomel; B Bourachot; M Yaniv
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

Review 4.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions.

Authors:  A Munck; P M Guyre; N J Holbrook
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

5.  Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production.

Authors:  D S Snyder; E R Unanue
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

6.  Glucocorticoid receptors and the cell cycle: evidence that the accumulation of glucocorticoid receptors during the S phase of the cell cycle is dependent on ribonucleic acid and protein synthesis.

Authors:  J A Cidlowski; N B Cidlowski
Journal:  Endocrinology       Date:  1982-05       Impact factor: 4.736

7.  Cellular stress and glucocorticoid hormones protect L929 mouse fibroblasts from tumor necrosis factor alpha cytotoxicity.

Authors:  M C Pagliacci; G Migliorati; M Smacchia; F Grignani; C Riccardi; I Nicoletti
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Current management of the septic shock patient: experimental basis for treatment.

Authors:  L B Hinshaw; B K Beller-Todd; L T Archer
Journal:  Circ Shock       Date:  1982

Review 10.  Corticosteroid-mediated immunoregulation in man.

Authors:  T R Cupps; A S Fauci
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

View more
  9 in total

1.  Dexamethasone inhibits TRAIL- and anti-cancer drugs-induced cell death in A549 cells through inducing NF-kappaB-independent cIAP2 expression.

Authors:  Youn Seup Kim; Jae Seuk Park; Young Koo Jee; Kye Young Lee
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

2.  Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats.

Authors:  P Yan; J Xu; Q Li; S Chen; G M Kim; C Y Hsu; X M Xu
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting.

Authors:  C Deval; S Mordier; C Obled; D Bechet; L Combaret; D Attaix; M Ferrara
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

4.  Cytokine modulation of liver annexin 1 expression during experimental endotoxemia.

Authors:  C de Coupade; M N Ajuebor; F Russo-Marie; M Perretti; E Solito
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Retinoic acid prevents experimental Cushing syndrome.

Authors:  M Páez-Pereda; D Kovalovsky; U Hopfner; M Theodoropoulou; U Pagotto; E Uhl; M Losa; J Stalla; Y Grübler; C Missale; E Arzt; G K Stalla
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 6.  Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence.

Authors:  Eri Shirakami; Sho Yamakawa; Kenji Hayashida
Journal:  Burns Trauma       Date:  2020-01-27

Review 7.  Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids.

Authors:  Hélène Prigent; Virginie Maxime; Djillali Annane
Journal:  Crit Care       Date:  2004-05-25       Impact factor: 9.097

8.  TNF-Α may mediate inflammasome activation in the absence of bacterial infection in more than one way.

Authors:  Susana Álvarez; Ma Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

9.  The levels of RAC3 expression are up regulated by TNF in the inflammatory response.

Authors:  Cecilia Viviana Alvarado; María Fernanda Rubio; Pablo Nicolas Fernández Larrosa; Laura Carolina Panelo; Pablo Javier Azurmendi; Marina Ruiz Grecco; Giselle Astrid Martínez-Nöel; Mónica Alejandra Costas
Journal:  FEBS Open Bio       Date:  2014-05-02       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.